(Q44963527)

7 December 2017

title

A flow cytometric method for determination of the interferon receptor IFNAR2 subunit in peripheral blood leukocyte subsets (English)

1 reference

7 December 2017

1 reference

Shiro Tochizawa

1

1 reference

7 December 2017

Seiji Akamatsu

2

1 reference

7 December 2017

Yoshihiro Sugiyama

3

1 reference

7 December 2017

Masahiro Muraguchi

4

1 reference

7 December 2017

Yasukazu Ohmoto

5

1 reference

7 December 2017

Yukihisa Ono

6

1 reference

7 December 2017

Hiroshi Ishikawa

7

1 reference

7 December 2017

Akira Tanigami

8

1 reference

7 December 2017

Takumi Sumida

9

1 reference

7 December 2017

Toyoki Mori

10

1 reference

7 December 2017

publication date

1 July 2004

1 reference

Journal of Pharmacological and Toxicological Methods

7 December 2017

published in

1 reference

7 December 2017

volume

50

1 reference

7 December 2017

issue

1

1 reference

7 December 2017

page(s)

59-66

1 reference

Effects of therapy with interferon-alpha on peripheral blood lymphocyte subsets and NK activity in patients with chronic hepatitis C

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.02.003

Natural killer cells in antiviral defense: function and regulation by innate cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.02.003

Biologic responses to IFN-alpha administration in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.02.003

Mechanisms for regulation of cellular responsiveness to human IFN-beta1a

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.02.003

Hepatic expression of type I interferon receptor for predicting response to interferon therapy in chronic hepatitis C patients: a comparison of immunohistochemical method vs. competitive polymerase chain reaction assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.02.003

Effectiveness of interferon-alpha therapy in chronic hepatitis C is associated with the amount of interferon-alpha receptor mRNA in the liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.02.003

Regulation of interferon receptor expression in human blood lymphocytes in vitro and during interferon therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.02.003

Downregulation of interferon alpha but not gamma receptor expression in vivo in the acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.02.003

Stimulation of NK cell cytotoxic potential of normal donors by two species of recombinant alpha interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.02.003

IFN-alpha receptor mRNA expression in a United States sample with predominantly genotype 1a/I chronic hepatitis C liver biopsies correlates with response to IFN therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.02.003

Enhancement of human natural cell-mediated cytotoxicity by interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.02.003

Expression of interferon receptor genes (IFNAR1 and IFNAR2 mRNA) in the liver may predict outcome after interferon therapy in patients with chronic genotype 2a or 2b hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.02.003

Changes in interferon receptors on peripheral blood mononuclear cells from patients with chronic hepatitis B being treated with interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.02.003

The human interferon alpha/beta receptor: characterization and molecular cloning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.02.003

Lymphocyte subset reference ranges in adult caucasians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.02.003

Hepatitis C virus infection upregulates expression of the type I interferon receptor in human peripheral blood mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.02.003

Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.02.003

Genetic transfer of a functional human interferon alpha receptor into mouse cells: cloning and expression of its cDNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.02.003

Expression of type I interferon receptor in liver and peripheral blood mononuclear cells in chronic hepatitis C patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.02.003

Analysis of the antiviral activities of natural IFN-alpha preparations and their subtype compositions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.02.003

Immunohistochemical analysis of hepatic interferon alpha-beta receptor level: relationship between receptor expression and response to interferon therapy in patients with chronic hepatitis C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.02.003

Quantitative analysis of interferon alpha/beta receptor mRNA in the liver of patients with chronic hepatitis C: correlation with serum hepatitis C virus-RNA levels and response to treatment with interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.02.003

A practical cytopathic effect/dye-uptake interferon assay for routine use in the clinical laboratory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.02.003

10.1016/J.VASCN.2004.02.003

7 January 2021

Identifiers

DOI

1 reference

7 December 2017

1 reference